Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Big Is The Xerostomia Therapeutics Market Today And What Is Its Future Size?

The therapeutic market size for xerostomia has experienced consistent growth in the past few years. Its valuation is projected to rise from $2.14 billion in 2024 to $2.24 billion in 2025, resulting in a compound annual growth rate (CAGR) of 4.7%. The surge observed in the historic timeframe is attributed to the escalating cases of xerostomia among the elderly, the proliferation of effective xerostomia products due to research and development, increasing cognizance of products related to xerostomia, a rise in underlying medical conditions, and the growing instance of chronic illnesses.

Expect a consistent surge in the xerostomia therapeutics market size over the next few years. By 2029, it is projected to hit “$2.69 billion, with a compound annual growth rate (CAGR) of 4.7%. Factors such as the wide accessibility of affordable medications, heightened occurrence of oral health ailments, increasing cognizance among healthcare professionals, government-driven initiatives, and burgeoning use of medication account for this growth within the forecast period. The forecast period will significantly be defined by trends like artificial saliva and saliva substitutes, technological progression and product novelty, personalized medicine alongside targeted therapies, telehealth coupled with remote monitoring, and the emergence of non-invasive therapies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15700&type=smp

Which Industry Forces Are Driving The Xerostomia Therapeutics Market Forward?

The surge in chemotherapy usage in cancer care is projected to drive the xerostomia therapeutics market’s expansion. These powerful drugs, used in chemotherapy, are designed to destroy or stall cancer cell growth. The growing popularity of chemotherapy in cancer care is primarily due to its ability to specifically target and eliminate cancer cells across the body. Saliva-inducing medications or mouthwashes fall under xerostomia therapeutics, improving saliva production and enhancing taste perception, thereby helping patients to eat and maintain proper nutrition. To illustrate, in January 2022, the National Cancer Institute, a US government agency, estimated that there are 18.1 million cancer survivors in the US, accounting for 5.4% of the total population. By 2032, the global number of cancer survivors is expected to reach 22.5 million, reflecting a 24.4% rise from the current estimate. Thus, the rising use of chemotherapy in cancer care is influencing the growth of the xerostomia therapeutics market.

How Does The Xerostomia Therapeutics Market Differ By Segment?

The xerostomia therapeutics market covered in this report is segmented –

1) By Type: Artificial Saliva Or Saliva Substitutes, Salivary Stimulants

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies, Hypermarkets And Supermarkets

3) By End-User: Adult, Pediatric

Subsegments:

1) By Artificial Saliva Or Saliva Substitutes: Oral Sprays, Gels, Lozenges, Mouthwashes

2) By Salivary Stimulants: Prescription Drugs, Over-The-Counter (Otc) Products, Chewing Gums And Lozenges

What New Opportunities Are Emerging From Trends In The Xerostomia Therapeutics Market?

Key players in the xerostomia therapeutics market are innovating patient-oriented, noninvasive treatments such as oral sprays to fulfill the need for efficient and easy-to-use solutions to manage dry mouth. Oral sprays provide precise delivery to dry areas in the mouth, offering targeted moisture and lubrication. For example, in July 2023, K Pharmaceuticals, a pharmaceutical firm from India, introduced Aquoral, a clinically tested oral spray aimed at alleviating dry mouth, otherwise known as xerostomia. This condition can be triggered by a range of factors, from medications to diseases, and can result in discomfort, eating and swallowing challenges, and dental health issues. Aquoral aids in providing lasting relief for up to six hours by establishing a durable protective shield over the mouth, minimizing moisture depletion and boosting comfort. Unlike conventional water-based treatments requiring regular reapplication, Aquoral employs proprietary Oxidized Glycerol Triesters (OGT), a lipid-based solution derived from plants, for enhanced protection.

Who Are The Primary Market Leaders In The Xerostomia Therapeutics Market?

Major companies operating in the xerostomia therapeutics market are Bayer AG, 3M Company, GlaxoSmithKline plc, Colgate-Palmolive Company, Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Cipla Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Synedgen Inc., Sunstar Suisse S.A., Advanz Pharma Corp., Pharmascience Inc., Mission Pharmacal Company, Dentaid Ltd., Cyclacel Pharmaceuticals Inc., Parnell Pharmaceuticals Holdings Ltd., Teva Pharmaceutical Industries Ltd., Forward Science Holding Inc., ICPA Health Products Ltd., CCMed Ltd., Bio Cosmetics Laboratories S.L., Quest Products LLC, Acacia Pharma, Saliwell Limited, OraCoat, Oralieve UK Ltd., OraPharma Inc., OraVital Inc

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/xerostomia-therapeutics-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Xerostomia Therapeutics Market?

North America was the largest region in the xerostomia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the xerostomia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15700&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model